Harvey Reiser

Clinical outcomes in a U.S. registration study of a new EDOF intraocular lens with a nondiffractive design

Cathleen M. McCabe, John P. Berdahl, Harvey Reiser et al. · Journal of Cataract & Refractive Surgery · 2022 · 61 citations · Full text

Once-daily nepafenac ophthalmic suspension 0.3% to prevent and treat ocular inflammation and pain after cataract surgery: Phase 3 study

Satish Modi, Robert Lehmann, Thomas R. Walters et al. · Journal of Cataract & Refractive Surgery · 2013 · 43 citations

Prospective randomised clinical trial to evaluate the safety and efficacy of nepafenac 0.1% treatment for the prevention of macular oedema associated with cataract surgery in patients with diabetic retinopathy

Ayala Pollack, Giovanni Staurenghi, Dana Sager et al. · British Journal of Ophthalmology · 2016 · 41 citations · Full text

Retinal oxygen consumption in vitro the effect of diabetes mellitus, oxygen and glucose

F. Scott Sutherland, Einar Stefánsson, Diane L. Hatchell et al. · Acta Ophthalmologica · 1990 · 24 citations

The REVIVE Study: Long Term Outcomes of a Novel Non-Diffractive Extended Vision IOL versus Monofocal Control IOL

Brian M. Shafer, Cathleen M. McCabe, Harvey Reiser et al. · Clinical ophthalmology · 2022 · 21 citations · Full text